You need to enable JavaScript to run this app.
Recon: Moderna plans to start Phase 3 coronavirus vaccine study on 27 July; Roche, Blueprint partner on targeted cancer drug
Recon
Michael Mezher
ReconMichael Mezher
ReconMichael Mezher